Skerratt Sarah E, West Christopher W
a Worldwide Medicinal Chemistry; Pfizer Global R&D ; Cambridge , UK.
b Worldwide Medicinal Chemistry; Pfizer Global R&D ; Durham , NC USA.
Channels (Austin). 2015;9(6):344-51. doi: 10.1080/19336950.2015.1075105.
Pain is a complex disease which can progress into a debilitating condition. The effective treatment of pain remains a challenge as current therapies often lack the desired level of efficacy or tolerability. One therapeutic avenue, the modulation of ion channel signaling by small molecules, has shown the ability to treat pain. However, of the 215 ion channels that exist in the human genome, with 85 ion channels having a strong literature link to pain, only a small number of these channels have been successfully drugged for pain. The focus of future research will be to fully explore the possibilities surrounding these unexplored ion channels. Toward this end, a greater understanding of ion channel modulation will be the greatest tool we have in developing the next generation of drugs for the treatment of pain.
疼痛是一种复杂的疾病,可能会发展成使人衰弱的状况。疼痛的有效治疗仍然是一项挑战,因为目前的疗法往往缺乏理想的疗效或耐受性。一种治疗途径,即通过小分子调节离子通道信号传导,已显示出治疗疼痛的能力。然而,在人类基因组中存在的215种离子通道中,有85种离子通道与疼痛有很强的文献关联,但其中只有少数几种通道已成功用于治疗疼痛的药物研发。未来研究的重点将是充分探索这些未被研究的离子通道的可能性。为此,更深入地了解离子通道调节将是我们开发下一代疼痛治疗药物的最有力工具。